UK's ImmuPharma drops on annual loss, lower year-end cash

ImmuPharma

11/05/2023 09:12

** Shares of ImmuPharma Plc  IMM.L  down as much as 12% at
2.54p, top pct losers among all London stocks 
    ** The specialist drug developer says it made no rev for the
     year ended Dec 31, compared with 118,350 pounds ($149,370)
in 2021
    ** Co reports annual loss of 3.8 mln pounds
    ** Says cash and cash equivalents at year-end amounted to 
0.7 mln pounds vs 1.6 mln pounds last year due to R&D
expenditure related to a study under its autoimmune clinical
programme
    ** Including session's losses, stock up ~42% this year 


    ($1 = 0.7923 pounds)
    




 (Reporting by Prerna Bedi in Bengaluru)
 ((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))